|
MXPA05005923A
(es)
*
|
2002-12-06 |
2005-09-21 |
Millennium Pharm Inc |
Metodos para la identificacion, valoracion y tratamiento de pacientes con terapia para la inhibicion de la proteasoma.
|
|
US8932808B1
(en)
|
2004-01-21 |
2015-01-13 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and compositions for determining a graft tolerant phenotype in a subject
|
|
CA2848463A1
(en)
|
2004-04-09 |
2005-10-27 |
Genomic Health, Inc. |
Gene expression markers for predicting response to chemotherapy
|
|
USRE46843E1
(en)
|
2005-03-14 |
2018-05-15 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and compositions for evaluating graft survival in a solid organ transplant recipient
|
|
JP2008537875A
(ja)
|
2005-03-14 |
2008-10-02 |
ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ |
固形臓器移植レシピエントにおいて移植片生着を評価するための方法および組成物
|
|
JP5904569B2
(ja)
|
2005-06-08 |
2016-04-13 |
ミレニアム ファーマシューティカルズ， インコーポレイテッドＭｉｌｌｅｎｎｉｕｍ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． |
癌治療を受けている患者の同定、判定および処置のための方法
|
|
US7785813B2
(en)
*
|
2005-06-20 |
2010-08-31 |
Regents Of The University Of California |
Prefoldin 4 in the treatment and diagnosis of cancer
|
|
EP1991701A4
(en)
*
|
2006-02-14 |
2010-03-17 |
Dana Farber Cancer Inst Inc |
COMPOSITIONS, KITS AND METHODS OF IDENTIFICATION, ASSESSMENT, PREVENTION AND THERAPY OF CANCER
|
|
EP2046973A4
(en)
*
|
2006-08-10 |
2010-04-07 |
Millennium Pharm Inc |
METHODS OF IDENTIFYING, EVALUATING, AND TREATING PATIENTS SUBJECTED TO ANTICANCER THERAPY
|
|
ES2417148T3
(es)
*
|
2007-06-08 |
2013-08-06 |
Genentech, Inc. |
Marcadores de expresión génica de la resistencia tumoral al tratamiento con inhibidor de HER2
|
|
US9551033B2
(en)
|
2007-06-08 |
2017-01-24 |
Genentech, Inc. |
Gene expression markers of tumor resistance to HER2 inhibitor treatment
|
|
US20080317768A1
(en)
*
|
2007-06-21 |
2008-12-25 |
Boeing Company |
Bioconjugated nanoparticles
|
|
WO2009042676A1
(en)
*
|
2007-09-24 |
2009-04-02 |
University Of South Florida |
Method for early detection of cancers
|
|
US20100027780A1
(en)
*
|
2007-10-04 |
2010-02-04 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Systems and methods for anonymizing personally identifiable information associated with epigenetic information
|
|
US20090094261A1
(en)
*
|
2007-10-04 |
2009-04-09 |
Jung Edward K Y |
Systems and methods for correlating epigenetic information with disability data
|
|
US20090099877A1
(en)
*
|
2007-10-11 |
2009-04-16 |
Hyde Roderick A |
Systems and methods for underwriting risks utilizing epigenetic information
|
|
US20090094281A1
(en)
*
|
2007-10-04 |
2009-04-09 |
Jung Edward K Y |
Systems and methods for transferring combined epigenetic information and other information
|
|
US20090094282A1
(en)
*
|
2007-10-04 |
2009-04-09 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Systems and methods for correlating past epigenetic information with past disability data
|
|
US20090094065A1
(en)
*
|
2007-10-04 |
2009-04-09 |
Hyde Roderick A |
Systems and methods for underwriting risks utilizing epigenetic information
|
|
US20090094067A1
(en)
*
|
2007-10-04 |
2009-04-09 |
Searete LLC, a limited liability corporation of |
Systems and methods for company internal optimization utilizing epigenetic data
|
|
US20090100095A1
(en)
*
|
2007-10-04 |
2009-04-16 |
Jung Edward K Y |
Systems and methods for reinsurance utilizing epigenetic information
|
|
US20090094047A1
(en)
*
|
2007-10-04 |
2009-04-09 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Systems and methods for predicting a risk utilizing epigenetic data
|
|
BRPI0820707A2
(pt)
|
2007-11-07 |
2015-06-16 |
Genentech Inc |
Métodos e composição para avaliar a responsividade do linfoma de células b para o tratamento com anticorpos anti-cd40
|
|
EP2641978A1
(en)
*
|
2008-05-12 |
2013-09-25 |
Genomic Health, Inc. |
Tests to predict responsiveness of cancer patients to chemotherapy treatment options
|
|
US20110201519A1
(en)
*
|
2008-08-18 |
2011-08-18 |
Sarwal Minnie M |
Methods and Compositions for Determining a Graft Tolerant Phenotype in a Subject
|
|
US7657446B1
(en)
*
|
2008-08-22 |
2010-02-02 |
Numoda Technologies, Inc. |
Automated identification of tasks that must be completed before a clinical trial database can be locked
|
|
CA2735182A1
(en)
*
|
2008-08-28 |
2010-03-04 |
Oncotherapy Science, Inc. |
Tbc1d7 as tumor marker and therapeutic target for cancer
|
|
US20100169115A1
(en)
*
|
2008-12-31 |
2010-07-01 |
Tamis Robert H |
System for matching individuals with health care providers and methods thereof
|
|
WO2010083121A1
(en)
|
2009-01-15 |
2010-07-22 |
The Board Of Trustees Of The Leland Stanford Junior University |
Biomarker panel for diagnosis and prediction of graft rejection
|
|
TW201030337A
(en)
*
|
2009-02-04 |
2010-08-16 |
Tzu Chi Buddhist General Hospital |
Method and kit for detecting cancers
|
|
EP2406389B1
(en)
*
|
2009-03-13 |
2019-05-08 |
Agios Pharmaceuticals, Inc. |
Methods and compositions for cell-proliferation-related disorders
|
|
US9617600B2
(en)
|
2009-04-18 |
2017-04-11 |
Genentech, Inc. |
Methods for assessing responsiveness of B-cell lymphoma to treatment with anti-CD40 antibodies
|
|
CA2944788C
(en)
|
2009-06-29 |
2023-08-22 |
Agios Pharmaceuticals, Inc. |
Compounds, and compositions thereof, which modulate pyruvate kinase m2, and methods of making same
|
|
CA2767616A1
(en)
|
2009-07-09 |
2011-01-13 |
The Scripps Research Institute |
Gene expression profiles associated with chronic allograft nephropathy
|
|
US20120252028A1
(en)
*
|
2009-08-14 |
2012-10-04 |
Michael Shtulman |
Target genes for cancer therapy
|
|
CA2793835C
(en)
|
2009-10-21 |
2021-07-20 |
Agios Pharmaceuticals, Inc. |
Methods and compositions for cell-proliferation-related disorders
|
|
WO2011050211A2
(en)
|
2009-10-21 |
2011-04-28 |
Agios Pharmaceuticals, Inc. |
Methods and compositions for cell-proliferation-related disorders
|
|
US9493833B1
(en)
*
|
2009-11-06 |
2016-11-15 |
The Regents Of The University Of California |
Methods for preventing induced synthesis of proteasomes in human cells
|
|
US20120231472A1
(en)
*
|
2009-11-07 |
2012-09-13 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
|
CA2782803C
(en)
|
2009-12-02 |
2020-09-01 |
The Board Of Trustees Of The Leland Stanford Junior University |
Biomarkers for determining an allograft tolerant phenotype
|
|
CA3256492A1
(en)
|
2010-01-11 |
2025-11-29 |
Genomic Health Inc |
Method to use gene expression to determine likelihood of clinical outcome of renal cancer
|
|
EP2550371A4
(en)
|
2010-03-25 |
2013-11-20 |
Univ Leland Stanford Junior |
PROTEIN AND GENE BIOMARKERS FOR EXTRACTING ORGAN TRANSPLANTS
|
|
US9309435B2
(en)
|
2010-03-29 |
2016-04-12 |
The Clorox Company |
Precursor polyelectrolyte complexes compositions comprising oxidants
|
|
US20110236582A1
(en)
|
2010-03-29 |
2011-09-29 |
Scheuing David R |
Polyelectrolyte Complexes
|
|
CA2798434A1
(en)
*
|
2010-05-13 |
2011-11-17 |
Universitaet Zuerich |
Discrete states for use as biomarkers
|
|
MX338883B
(es)
|
2010-07-27 |
2016-05-04 |
Genomic Health Inc |
Metodo para usar expresion de gen para determinar el pronostico de cancer de prostata.
|
|
US20140322705A1
(en)
*
|
2010-08-20 |
2014-10-30 |
Thomas Jefferson University |
Cancer diagnostic and cancer therapeutic
|
|
US8962261B2
(en)
|
2011-04-06 |
2015-02-24 |
The Board Of Trustees Of The Leland Stanford Junior University |
Autoantibody biomarkers for IGA nephropathy
|
|
KR101873543B1
(ko)
|
2011-05-03 |
2018-07-02 |
아지오스 파마슈티컬스 아이엔씨. |
치료에 사용하기 위한 피루베이트 키나아제 활성제
|
|
CN102827073A
(zh)
|
2011-06-17 |
2012-12-19 |
安吉奥斯医药品有限公司 |
治疗活性组合物和它们的使用方法
|
|
CN102827170A
(zh)
|
2011-06-17 |
2012-12-19 |
安吉奥斯医药品有限公司 |
治疗活性组合物和它们的使用方法
|
|
SI2742356T1
(sl)
|
2011-08-11 |
2016-06-30 |
Janssen Pharmaceutica N.V. |
Prediktorji pri zdravljenju raka
|
|
CA2853822A1
(en)
|
2011-10-28 |
2013-05-02 |
Millennium Pharmaceuticals, Inc. |
Biomarkers of response to nae inhibitors
|
|
US20150184246A1
(en)
*
|
2011-11-11 |
2015-07-02 |
Millennium Pharmaceuticals, Inc. |
Biomarkers of response to proteasome inhibitors
|
|
SG11201403878QA
(en)
|
2012-01-06 |
2014-08-28 |
Agios Pharmaceuticals Inc |
Therapeutically active compounds and their methods of use
|
|
US9474779B2
(en)
|
2012-01-19 |
2016-10-25 |
Agios Pharmaceuticals, Inc. |
Therapeutically active compositions and their methods of use
|
|
EP2812338A4
(en)
*
|
2012-01-24 |
2015-09-23 |
Millennium Pharm Inc |
METHOD FOR THE TREATMENT OF NASOPHARYNGEAL CANCER
|
|
CA2862492A1
(en)
*
|
2012-01-24 |
2013-08-01 |
Millennium Pharmaceuticals, Inc. |
Methods of treatment of cancer
|
|
US10085987B2
(en)
|
2012-01-27 |
2018-10-02 |
Thomas Jefferson University |
MCT protein inhibitor-related prognostic and therapeutic methods
|
|
SG11201404390WA
(en)
|
2012-01-31 |
2014-08-28 |
Genomic Health Inc |
Gene expression profile algorithm and test for determining prognosis of prostate cancer
|
|
HK1213798A1
(zh)
|
2012-10-15 |
2016-07-15 |
安吉奥斯医药品有限公司 |
治療性化合物和組合物
|
|
EP3729958B1
(en)
*
|
2013-03-15 |
2023-05-03 |
Mayo Foundation for Medical Education and Research |
Identification and monitoring of monoclonal immunoglobulins by molecular mass
|
|
EP2986290A4
(en)
|
2013-04-19 |
2017-01-04 |
Thomas Jefferson University |
Caveolin-1 related methods for treating glioblastoma with temozolomide
|
|
ES2829415T3
(es)
|
2013-05-30 |
2021-05-31 |
Genomic Health Inc |
Algoritmo de perfil de expresión génica para calcular una puntuación de recurrencia para un paciente con cáncer de riñón
|
|
WO2015003360A2
(en)
|
2013-07-11 |
2015-01-15 |
Agios Pharmaceuticals, Inc. |
Therapeutically active compounds and their methods of use
|
|
CA2917671A1
(en)
|
2013-07-11 |
2015-01-15 |
Agios Pharmaceuticals, Inc. |
2,4-or 4,6-diaminopyrimidine compounds as idh2 mutants inhibitors for the treatment of cancer
|
|
WO2015003355A2
(en)
|
2013-07-11 |
2015-01-15 |
Agios Pharmaceuticals, Inc. |
Therapeutically active compounds and their methods of use
|
|
US9579324B2
(en)
|
2013-07-11 |
2017-02-28 |
Agios Pharmaceuticals, Inc |
Therapeutically active compounds and their methods of use
|
|
US20150031627A1
(en)
|
2013-07-25 |
2015-01-29 |
Agios Pharmaceuticals, Inc |
Therapeutically active compounds and their methods of use
|
|
EA038246B1
(ru)
*
|
2013-08-08 |
2021-07-29 |
Оникс Терапьютикс, Инк. |
Уровни экспрессии иммуноглобулинов в качестве биологического маркера для реакции на ингибитор протеасом
|
|
CA2942072C
(en)
|
2014-03-14 |
2022-07-26 |
Agios Pharmaceuticals, Inc. |
Pharmaceutical compositions and use of (s)-1-(2-chlorophenyl)-2-((3,3-difluorocyclobutyl)amino)-2-oxoethyl)-1-( 4-cyanopyridin-2-yl)-n-( 5-fluoropyridin-3-yl)-5-oxopyrrolidine-2-carboxamide
|
|
US10267806B2
(en)
|
2014-04-04 |
2019-04-23 |
Mayo Foundation For Medical Education And Research |
Isotyping immunoglobulins using accurate molecular mass
|
|
EP4050103A1
(en)
|
2014-04-07 |
2022-08-31 |
Minerva Biotechnologies Corporation |
Anti-nme antibody
|
|
US10443100B2
(en)
|
2014-05-22 |
2019-10-15 |
The Scripps Research Institute |
Gene expression profiles associated with sub-clinical kidney transplant rejection
|
|
US11104951B2
(en)
|
2014-05-22 |
2021-08-31 |
The Scripps Research Institute |
Molecular signatures for distinguishing liver transplant rejections or injuries
|
|
US20160018414A1
(en)
*
|
2014-07-21 |
2016-01-21 |
The Florida International University Board Of Trustees |
SAB as a Biomarker for Degenerative Diseases and Therapeutic Sensitivity in Cancers
|
|
US10690676B2
(en)
|
2014-07-29 |
2020-06-23 |
Mayo Roundation for Medical Education and Research |
Quantifying monoclonal antibody therapeutics by LC-MS/MS
|
|
WO2016161153A2
(en)
*
|
2015-04-01 |
2016-10-06 |
The Regents Of The University Of California |
Prognostic and diagnostic methods for colorectal cancer
|
|
DK3307271T3
(da)
|
2015-06-11 |
2023-10-09 |
Agios Pharmaceuticals Inc |
Fremgangsmåder til anvendelse af pyruvatkinase-aktivatorer
|
|
US11209439B2
(en)
|
2015-09-24 |
2021-12-28 |
Mayo Foundation For Medical Education And Research |
Identification of immunoglobulin free light chains by mass spectrometry
|
|
MA71411A
(fr)
|
2015-10-15 |
2025-04-30 |
Les Laboratoires Servier |
Polythérapie pour le traitement de tumeurs malignes
|
|
DK3362066T3
(da)
|
2015-10-15 |
2021-11-22 |
Les Laboratoires Servier Sas |
Kombinationsterapi til behandling af maligniteter
|
|
US11823799B2
(en)
*
|
2015-11-20 |
2023-11-21 |
Universite De Strasbourg |
Method for identifying personalized therapeutic strategies for patients affected with a cancer
|
|
MX391039B
(es)
*
|
2016-04-07 |
2025-03-21 |
Univ Leland Stanford Junior |
Diagnostico no invasivo por medio de la secuenciacion del adn libre de celulas 5-hidroxi-metilado.
|
|
US20170298422A1
(en)
|
2016-04-18 |
2017-10-19 |
The Board Of Trustees Of The Leland Stanford Junior University |
Simultaneous single-molecule epigenetic imaging of dna methylation and hydroxymethylation
|
|
US10955420B2
(en)
|
2016-09-07 |
2021-03-23 |
Mayo Foundation For Medical Education And Research |
Identification and monitoring of cleaved immunoglobulins by molecular mass
|
|
EP3559043A4
(en)
|
2016-12-23 |
2020-08-05 |
Bluefin Biomedicine, Inc. |
ANTI-SEZ6L2 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES
|
|
ES2916450T3
(es)
|
2017-07-21 |
2022-07-01 |
Liquid Biopsy Res Llc |
Método para la detección de discrasia de células plasmáticas
|
|
US12153052B2
(en)
|
2017-09-13 |
2024-11-26 |
Mayo Foundation For Medical Education And Research |
Identification and monitoring of immunoglobulin J chains
|
|
US11946937B2
(en)
|
2017-09-13 |
2024-04-02 |
Mayo Foundation For Medical Education And Research |
Identification and monitoring of apoptosis inhibitor of macrophage
|
|
US20190233900A1
(en)
*
|
2018-02-01 |
2019-08-01 |
Nantomics, Llc |
Biomarkers in de novo pyrimidine synthesis pathways and chemoresistance
|
|
US11013733B2
(en)
|
2018-05-16 |
2021-05-25 |
Forma Therapeutics, Inc. |
Inhibiting mutant isocitrate dehydrogenase 1 (mlDH-1)
|
|
US10532047B2
(en)
|
2018-05-16 |
2020-01-14 |
Forma Therapeutics, Inc. |
Solid forms of ((S)-5-((1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino)-1-methyl-6-oxo-1,6-dihydropyridine-2-carbonitrile
|
|
US11013734B2
(en)
|
2018-05-16 |
2021-05-25 |
Forma Therapeutics, Inc. |
Treating patients harboring an isocitrate dehydrogenase-1 (IDH-1) mutation
|
|
EP3720442B1
(en)
|
2018-05-16 |
2022-12-28 |
Forma Therapeutics, Inc. |
Inhibiting mutant idh-1
|
|
US11311527B2
(en)
|
2018-05-16 |
2022-04-26 |
Forma Therapeutics, Inc. |
Inhibiting mutant isocitrate dehydrogenase 1 (mIDH-1)
|
|
US10769307B2
(en)
|
2018-05-30 |
2020-09-08 |
Bank Of America Corporation |
Processing system using natural language processing for performing dataset filtering and sanitization
|
|
US12188936B2
(en)
|
2018-06-01 |
2025-01-07 |
Lunella Biotech, Inc. |
Biomarkers and therapeutics for endocrine therapy resistance
|
|
US10980788B2
(en)
|
2018-06-08 |
2021-04-20 |
Agios Pharmaceuticals, Inc. |
Therapy for treating malignancies
|
|
CN109190713A
(zh)
*
|
2018-09-29 |
2019-01-11 |
王海燕 |
基于血清质谱自适应稀疏特征选择的卵巢癌微创快检技术
|
|
SG10201811119XA
(en)
*
|
2018-12-12 |
2020-07-29 |
Sengenics Sdn Bhd |
Detection of biomarkers for non-small cell lung cancer
|
|
CN109633142B
(zh)
*
|
2018-12-22 |
2021-08-27 |
中国人民解放军第四军医大学 |
一种急性髓细胞性白血病诊断模型的建立方法及其应用
|
|
WO2020149523A1
(ko)
*
|
2019-01-17 |
2020-07-23 |
사회복지법인 삼성생명공익재단 |
항암제 반응성 예측용 바이오마커 및 이의 용도
|
|
CN113727602B
(zh)
*
|
2019-02-04 |
2023-10-03 |
米纳瓦生物技术公司 |
抗nme抗体及治疗癌症或癌症转移的方法
|
|
US20220152071A1
(en)
*
|
2019-04-02 |
2022-05-19 |
Northwestern University |
Markers of efficacy of topoisomerase poisons
|
|
WO2021003176A1
(en)
*
|
2019-07-01 |
2021-01-07 |
Rutgers, The State University Of New Jersey |
Identification of patients that will respond to chemotherapy
|
|
US20220364178A1
(en)
*
|
2019-08-14 |
2022-11-17 |
University Of Massachusetts |
Urinary rna signatures in renal cell carcinoma (rcc)
|
|
WO2021108043A1
(en)
|
2019-11-27 |
2021-06-03 |
University Of Cincinnati |
Assessing treatment response with estimated number of tumor cells
|
|
RU2750103C1
(ru)
*
|
2020-02-21 |
2021-06-22 |
Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр онкологии имени Н.Н. Петрова" Министерства здравоохранения Российской Федерации |
Способ дифференциальной диагностики диффузных в-клеточных крупноклеточных лимфом
|
|
IL298780A
(en)
|
2020-06-08 |
2023-02-01 |
Minerva Biotechnologies Corp |
Anti-nme antibody and method of treating cancer or cancer metastasis
|
|
CN116075318A
(zh)
|
2020-06-26 |
2023-05-05 |
米纳瓦生物技术公司 |
抗nme抗体及治疗癌症或癌症转移的方法
|
|
CN112501278A
(zh)
*
|
2020-12-03 |
2021-03-16 |
中国医学科学院病原生物学研究所 |
Smim26作为结核病诊断分子标识的用途
|
|
CN113092757B
(zh)
*
|
2021-02-23 |
2024-02-06 |
承德医学院 |
一种肺癌肝转移早期诊断试剂盒及制备使用方法
|
|
CN115372618B
(zh)
*
|
2022-09-19 |
2025-01-14 |
首都医科大学附属北京胸科医院 |
一种检测蛋白标志物水平的试剂在制备用于评估肿瘤治疗效果的诊断产品中的应用
|
|
CN116500266B
(zh)
*
|
2023-03-07 |
2025-06-17 |
南通大学附属医院 |
MRPS21基因及其RNAi干扰系统的应用
|